Not elucidating the potential side effects might lead to medicine intolerance, reduction of dosage, a gap in the administration of therapy or even a discontinuation of these targeted therapies resulting in a loss of treatment opportunity for the patients. However, these new treatment strategies may give rise to difficulties and should be ascertained in order to manage these effects with appropriate supportive treatment. IntroductionĪdvances in therapeutics in the field of oncology have improved life expectancy and the quality of life of the patients. KeywordsĬlinical experience homeopathy integrative oncology isotherapy supportive care targeted therapies 1. Clinical trials could be carried out following the designs and protocols presented in this article. Homeopathy, organotherapy and isotherapy, by supporting the whole body and treating the major side effects, might improve observance and consequently therapeutic results. Facilitating tolerance and acceptance of targeted therapies is very important in oncology in order to fully benefit from the TT efficacy. It has been prescribed to approximately 5,000 patients over 25 years including those patients who were given hormone therapy. This therapeutic regimen is well accepted and well tolerated.
If needs be, the eponymous organotherapy of the organ most affected by the side effects can be added in 4c (10 -8). The originality of the treatment lies in combining a symptomatic diluted and dynamised homeopathic medicine with the patient’s constitutional homeopathic medicine as well as the isotherapeutic agent used for targeted therapy in 7c (10 -14). Based on the author’s clinical experience and published studies, a therapeutic regimen for systematic supportive care of TT is proposed in this study. In the absence of drug interaction and significant side effects, homeopathy used in supportive care improves the quality of life of patients, compliance with oncological treatments and consequently their survival. With small therapeutic indices, the reduction in dosage or spacing out of the doses of TT due to side effects, represents a significant loss of treatment opportunity for the patients. The application of targeted therapies (TT) in oncology has prolonged survivals and even enabled complete remission of cancers previously considered incurable. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited. Improving Tolerance and Compliance of New Targeted Therapies with Homeopathy: A Major Challenge in Oncology. OBM Integrative and Complementary Medicine 2022, Volume 7, Issue 3, doi: 10.21926/obm.icm.2203026 Received: Ap| Accepted: J| Published: July 11, 2022 Special Issue: Homeopathy in Oncological Integrative Care Surgery, 5, place des Halles 67000 Strasbourg, France Clinique de la Toussaint, 11, rue de la Toussaint 67000 Strasbourg, France Saint Vincent Hospital Group, Integrative Care Outpatient Department.
0 kommentar(er)
